PRKCA and neoplasm: Activated PKCα was conjugated with Dynamin 2 (DNM2), enhanced the generation of DNM2, and facilitated the release of PEVs from platelets, while PEVs transferred miR-1297 from platelets to breast cancer cells to promote tumor progression.